$68 Million is the total value of DCVC Opportunity Fund II GP, LLC's 5 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RXRX | Recursion Pharmaceuticals, Inc. | $32,162,000 | +13.7% | 3,951,141 | 0.0% | 47.32% | +50.0% | |
Rocket Lab USA, Inc. | $27,300,000 | -52.9% | 7,203,035 | 0.0% | 40.16% | -37.9% | ||
DM | Desktop Metal, Inc. | $1,584,000 | -53.6% | 720,166 | 0.0% | 2.33% | -38.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Rocket Lab USA, Inc. | 4 | Q3 2022 | 64.7% |
Recursion Pharmaceuticals, Inc. | 4 | Q3 2022 | 54.4% |
Desktop Metal, Inc. | 4 | Q3 2022 | 3.8% |
Rigetti Computing, Inc. | 2 | Q3 2022 | 9.9% |
Cloudflare, Inc. | 2 | Q3 2022 | 0.4% |
SentinelOne, Inc. | 1 | Q4 2021 | 19.8% |
View DCVC Opportunity Fund II GP, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR/A | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-02-14 |
4 | 2021-04-22 |
3 | 2021-04-15 |
View DCVC Opportunity Fund II GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.